PA-GREENE-TWEED
10.11.2016 13:03:36 CET | Business Wire | Press release
For years, Greene, Tweed has offered the most advanced sealing solutions in the upstream and downstream energy markets. Our innovative seals – utilizing our proprietary materials such as Arlon® and Chemraz® -- can be used in even the harshest applications, withstanding pressures up to 30,000 psi and temperatures ranging from subzero to 500°F (260°C).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161110005387/en/
Greene, Tweed’s customers rely on our unmatched engineering expertise for developing customized solutions to their unique needs. However, we recognize that our customers also need fast, reliable access to their most frequently specified seals. That’s why Greene, Tweed is introducing three new catalogs for standard sealing solutions:
- O-ring and Back-Up Ring (BUR) Catalog
- MSE ® Catalog
- G-T ® Rings Catalog
These catalogs provide our customers access to decades’ worth of material expertise and product application knowledge, and the ability to order pre-engineered, industry-standard products with ease. And by eliminating the need for product engineering with each order, customers can expect to see quicker turnaround times and gain efficiency.
The catalogs allow engineers and designers to build their own part number, quickly find what material is needed based on the chemicals, pressure and temperatures present within specific operating environments and get easy-to-follow installation instructions and guidance about how to use each type of seal. They also include Greene, Tweed’s design standards, which have been used in thousands of applications over the years.
To learn more about Greene, Tweed’s new product catalogs, visit our Pre-Engineered Sealing Solutions page for more information.
About Greene, Tweed
Greene, Tweed is a privately held company, diversified across multiple industries, and uniquely positioned to invest in and respond to dynamic market changes. Our engineering and technical strength enables Greene, Tweed to solve our customers’ greatest challenges, helping to improve their productivity and profitability through close partnership and collaboration. Greene, Tweed’s Energy business is led by Ron Callaway, an industry veteran with over 26 years of experience providing solutions for critical applications.
Greene, Tweed products are sold and distributed worldwide. For additional information, call +1.215.256.9521, or visit our website at www.gtweed.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20161110005387/en/
Contact:
Greene, Tweed
Chris Aldred
Corporate Marketing
+1-267-932-5389
caldred@gtweed.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s26.5.2026 08:00:00 CEST | Press release
Study Topline results will be released around the end of Q2 2026 BIA 28-6156 is being developed as a potential first-in-class disease-modifying therapy in GBA-PD Bial was present at the GBA1 conference and is currently attending the World Parkinson Congress Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced the completion of the treatment period in its Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). Upon completion of the 78-week double-blind treatment period and all scheduled safety follow-ups, data cleaning and analysis are currently ongoing. Topline results will be released around the end of Q2. A status report on the ACTIVATE study was presented in an oral presentation at the 3rd International GBA1 Meeting 2026. The team is currently attending the 7th World Parkinson Congress, taking place in Pho
Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release
Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom